Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood-Reference-Cited by-同舟云学术

Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood

Published:2019-10 Issue: Volume:114 Page:139-148
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Brekke Ole-Lars,Christiansen Dorte,Kisserli Aymric,Fure Hilde,Dahl Jim Andre,Donvito Béatrice,Reveil Brigitte,Ludviksen Judith Krey,Tabary Thierry,Mollnes Tom Eirik,Cohen Jacques H.M.

Funder

Independent Order of Odd Fellows

Landsforeningen for Hjerte- og Lungesyke

Helse Nord RHF

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference37 articles.

1. Origin of the fourth component of complement related Chido and Rodgers blood group antigens;Atkinson;Complement,1988

2. A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system;Benacerraf;J. Exp. Med.,1959

3. An international serum standard for application in assays to detect human complement activation products;Bergseth;Mol. Immunol.,2013

4. CR1 and CR1-like: the primate immune adherence receptors;Birmingham;Immunol. Rev.,2001

5. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood;Brekke;J. Leukoc. Biol.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trypanosoma brucei Invariant Surface gp65 Inhibits the Alternative Pathway of Complement by Accelerating C3b Degradation;The Journal of Immunology;2023-07-19

2. Erythrocytes: Member of the immune system that should not be ignored;Critical Reviews in Oncology/Hematology;2023-07

3. Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics;Pharmacological Reviews;2021-03-09